Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 68,040 | 63,158 | 57,683 | 64,575 | 55,011 |
Operating Income | -68,040 | -63,158 | -57,683 | -64,575 | -55,011 |
Other Income | 1,843 | 2,184 | 3,203 | 3,390 | 4,309 |
Pre-tax Income | -66,197 | -60,974 | -54,480 | -61,185 | -50,702 |
Income Tax | N/A | N/A | N/A | -155 | 33 |
Net Income Continuous | -66,197 | -60,974 | -54,480 | -61,030 | -50,735 |
Net Income | $-66,197 | $-60,974 | $-54,480 | $-61,030 | $-50,735 |
EPS Basic Total Ops | -0.52 | -0.53 | -0.50 | -0.60 | -0.50 |
EPS Basic Continuous Ops | -0.52 | -0.53 | -0.50 | -0.59 | -0.50 |
EPS Diluted Total Ops | -0.52 | -0.53 | -0.50 | -0.60 | -0.50 |
EPS Diluted Continuous Ops | -0.52 | -0.53 | -0.50 | -0.59 | -0.50 |
EBITDA(a) | $-64,813 | $-61,043 | $-55,846 | $-63,180 | $-54,534 |